# Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration

> **NCT02122159** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of California, Los Angeles**

## Conditions studied

- Myopic Macular Degeneration

## Interventions

- **BIOLOGICAL:** MA09-hRPE Cellular Therapy

## Key facts

- **NCT ID:** NCT02122159
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study to be revised. Future plans to be determined.
- **Last updated:** 2016-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02122159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02122159, "Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02122159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*